who-we-are diversity-equity-inclusion-dei 
ACRP blog
APRIL 30, 2023
Achieving a clinical research environment that is more diverse, equitable, and inclusive relies on all stakeholders deliberately moving from intention to action, attendees of the ACRP 2023 conference in Dallas, Texas, were told on Sunday morning (April 30).
ACRP blog
FEBRUARY 14, 2024
In addition, the National Academy of Sciences announced an important upcoming public workshop, titled Toward a Framework to Improve Diversity and Inclusion in Clinical Trials. What key progress can you report for advancing DEI in clinical research? The issue is front and center and we are engaged—everyone.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Worldwide Clinical Trials
NOVEMBER 3, 2022
In April 2022, the Food and Drug Administration (FDA) issued draft guidance on developing a “Race and Ethnicity Diversity Plan” for clinical trials. We’re seeing more sponsors getting requests from agencies to include more diverse populations across ethnicities, socioeconomic statuses and other groups,” he said. altogether.”.
Velocity Clinical Research
APRIL 5, 2024
Velocity recently asked some key employees to come together and discuss a wide array of issues impacting diversity, equity, and inclusion (DEI) in clinical trials. Site selection is “an exceptionally important issue that takes an incredible amount of planning. The issue is personal for Lang. “It’s
WCG Clinical
JULY 11, 2023
Lack of diversity in clinical trials can impair quality, increase costs, and put patient safety at risk. The barriers to diversity have been well-documented, but, despite significant progress, the industry still struggles to overcome them. If we have to go door to door [which we did during COVID], we need to do that.”
XTalks
AUGUST 4, 2022
Cardiovascular clinical trials need to have a diversity plan because there can be a difference in disease burden when comparing people of different race and ethnicity. The US Food and Drug Administration (FDA) is emphasizing the need for diversity in clinical trials. The Diversity of the US Population.
WCG Clinical
JANUARY 4, 2024
While the industry continues to adjust in a post-COVID world, as of this publication we expect clinical trial starts in 2024 to be up slightly over 2023. Below, our experts will connect you with insights to prepare you for what we expect to be another progressive year in the industry. Despite this improvement, disconnects remain.
Expert insights. Personalized for you.
98 
Let's personalize your content